首頁 > 市場調查報告書 > 製藥

自體免疫疾病

市場調查報告書

商品編碼

1541802

2024-2032 年按產品（免疫抑制劑、免疫促效劑）、應用（腫瘤、呼吸、HIV 等）和地區分類的免疫調節劑市場報告

Immunomodulators Market Report by Product (Immunosuppressants, Immunostimulants), Application (Oncology, Respiratory, HIV, and Others), and Region 2024-2032

出版日期: 2024年08月10日 | 出版商:

IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年全球免疫調節劑市場規模達2,112億IMARC Group。

免疫調節劑是一組用於改變針對傳染病、免疫缺陷和抗體轉移改變的免疫反應的藥物。這些藥物通常包括單株抗體、細胞激素、左旋咪唑和卡介苗（BCG）。它們廣泛用於治療癌症、氣喘、腫瘤、遺傳性血管性水腫和自體免疫疾病，如天皰瘡、紅斑性狼瘡、過敏和類風濕關節炎。如今，一些醫療保健提供者推薦免疫調節劑與其他藥物（例如生物製劑）一起用於治療發炎性腸道疾病（IBD）。

免疫調節劑市場趨勢：

由於快速城市化、收入水平上漲以及加工食品消費的增加，個人不健康的生活方式導致全球慢性病盛行率顯著上升。這進一步增加了對器官移植的需求，這對作為器官移植受者有前途的治療劑的局部免疫調節劑的需求產生了積極影響。此外，人口老化的加劇和事故數量的增加也增加了器官衰竭的風險。因此，一些管理和非管理當局正在鼓勵器官捐贈，這反過來又促進了全球局部免疫調節劑的銷售。除此之外，發炎性腸道疾病和自體免疫疾病的盛行率不斷上升也推動了市場的成長。免疫調節劑也用於聯合治療，以減少對類固醇的長期需求，防止復發，並治療對抗生素無反應的疾病。此外，包括氟伏沙明、托珠單抗和巴瑞替尼合併瑞德西韋在內的多種免疫調節劑正在用於治療冠狀病毒病 (COVID-19) 住院患者。除此之外，一些候選產品目前正處於後期臨床試驗階段。這些產品的開發預計將擴大免疫調節劑在治療各種危及生命的疾病方面的應用。

本報告回答的關鍵問題：

迄今為止，全球免疫調節劑市場表現如何，未來幾年將如何表現？
COVID-19 對全球免疫調節劑市場有何影響？
主要區域市場有哪些？
基於產品的市場區隔是什麼？
基於應用程式的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球免疫調節劑市場的結構如何？
產業競爭程度如何？

Immunomodulators are a group of drugs used to modify an immune response against infectious diseases, immunodeficiency, and alterations in antibody transfer. These drugs generally include monoclonal antibodies, cytokines, levamisole, and Bacillus Calmette-Guerin (BCG). They are widely used to treat cancer, asthma, tumors, hereditary angioedema, and autoimmune disorders like pemphigus, lupus, allergies, and rheumatoid arthritis. Nowadays, several healthcare providers are recommending immunomodulators with other agents, such as biologics, for managing inflammatory bowel disease (IBD).

Immunomodulators Market Trends:

The unhealthy lifestyles of individuals on account of rapid urbanization, inflating income levels, and the increasing consumption of processed food products has led to a significant rise in the prevalence of chronic diseases worldwide. This is further escalating the need for organ transplantation, which is positively influencing the demand for topical immunomodulators as a promising therapeutic agent in organ transplant recipients. Moreover, the rising aging population and the growing number of accidents are also increasing the risk of organ failure. Consequently, several governing and non-governing authorities are encouraging organ donation, which, in turn, is boosting the sales of topical immunomodulators worldwide. Apart from this, the increasing prevalence of IBD and autoimmune disorders is bolstering the market growth. Immunomodulators are also utilized in combination therapy to decrease the long-term need for steroids and prevent recurring flares and treat diseases that do not respond to antibiotics. Furthermore, several immunomodulators, including Fluvoxamine, Tocilizumab, and Baricitinib with Remdesivir, are finding application for treating hospitalized patients with coronavirus disease (COVID-19). Besides this, several product candidates are currently in late-stage clinical trials. The development of these products is anticipated to expand the applications of immunomodulators for treating various life-threatening diseases.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunomodulators market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and application.

Breakup by Product:

Immunosuppressants

Antibodies

Calcineurin Inhibitors

Glucocorticoids

Antimetabolites

Others

Immunostimulants

Vaccines

Antibodies

Others

Breakup by Application:

Oncology

Respiratory

HIV

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc.

Key Questions Answered in This Report:

How has the global immunomodulators market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global immunomodulators market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global immunomodulators market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Immunomodulators Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Immunosuppressants
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Antibodies
  - 6.1.2.2 Calcineurin Inhibitors
  - 6.1.2.3 Glucocorticoids
  - 6.1.2.4 Antimetabolites
  - 6.1.2.5 Others
- 6.1.3 Market Forecast
6.2 Immunostimulants
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Vaccines
  - 6.2.2.2 Antibodies
  - 6.2.2.3 Others
- 6.2.3 Market Forecast

7 Market Breakup by Application

7.1 Oncology
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Respiratory
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 HIV
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Amgen Inc.
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 Biogen Inc.
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
  - 13.3.2.3 Financials
  - 13.3.2.4 SWOT Analysis
- 13.3.3 Bristol-Myers Squibb Company
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
  - 13.3.3.4 SWOT Analysis
- 13.3.4 Eli Lilly and Company
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 F. Hoffmann-La Roche AG
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 SWOT Analysis
- 13.3.6 Johnson & Johnson
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
  - 13.3.6.3 Financials
  - 13.3.6.4 SWOT Analysis
- 13.3.7 Merck & Co. Inc.
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
  - 13.3.7.4 SWOT Analysis
- 13.3.8 Novartis AG
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
  - 13.3.8.3 Financials
  - 13.3.8.4 SWOT Analysis
- 13.3.9 Pfizer Inc.
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
  - 13.3.9.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Immunomodulators Market: Major Drivers and Challenges
Figure 2: Global: Immunomodulators Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Immunomodulators Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Immunomodulators Market: Breakup by Product (in %), 2023
Figure 5: Global: Immunomodulators Market: Breakup by Application (in %), 2023
Figure 6: Global: Immunomodulators Market: Breakup by Region (in %), 2023
Figure 7: Global: Immunomodulators (Immunosuppressants) Market: Sales Value (in Million US$), 2018 & 2023
Figure 8: Global: Immunomodulators (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 9: Global: Immunomodulators (Immunostimulants) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Immunomodulators (Immunostimulants) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Immunomodulators (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Immunomodulators (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Immunomodulators (Respiratory) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Immunomodulators (Respiratory) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Immunomodulators (HIV) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Immunomodulators (HIV) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Immunomodulators (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Immunomodulators (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: North America: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: North America: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: United States: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: United States: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Canada: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Canada: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Asia-Pacific: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Asia-Pacific: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: China: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: China: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Japan: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Japan: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: India: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: India: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: South Korea: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: South Korea: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Australia: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Australia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Indonesia: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Indonesia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Others: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Europe: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Europe: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Germany: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Germany: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: France: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: France: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: United Kingdom: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: United Kingdom: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Italy: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Italy: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Spain: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Spain: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Russia: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Russia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Others: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Latin America: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Latin America: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Brazil: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Brazil: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Mexico: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Mexico: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Others: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Middle East and Africa: Immunomodulators Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Middle East and Africa: Immunomodulators Market: Breakup by Country (in %), 2023
Figure 67: Middle East and Africa: Immunomodulators Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Global: Immunomodulators Industry: SWOT Analysis
Figure 69: Global: Immunomodulators Industry: Value Chain Analysis
Figure 70: Global: Immunomodulators Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Immunomodulators Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Immunomodulators Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Immunomodulators Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Immunomodulators Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 5: Global: Immunomodulators Market: Competitive Structure
Table 6: Global: Immunomodulators Market: Key Players

02-2729-4219

+886-2-2729-4219